This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device.

Low-Dose Androderm® 2mg/4mg Smaller Patch, Reliable Results

WHAT IS ANDRODERM® 2 MG/4 MG?

Androderm® 2 mg/4 mg is a smaller, once-daily skin patch that delivers 20% less testosterone* and the reliable efficacy you and your doctor expect. Androderm® 2 mg/4 mg restored average testosterone concentrations to normal in most patients after 28 days of treatment.

Androderm® 2 mg/4 mg also has a strong safety profile, with little risk of testosterone transference to partners or children.

*Compared to Androderm® 2.5 mg/5 mg

Androderm® is used to treat adult males who have low or no testosterone.

IMPORTANT SAFETY INFORMATION
You should not use Androderm® if you have breast cancer, known or suspected prostate cancer, or if you have pre-existing heart, kidney, or liver disease. You should also not use Androderm® if you are a pregnant or breastfeeding woman, as testosterone may cause fetal harm. If you have an enlarged prostate (BPH), you should be monitored for worsening signs and symptoms. Women and children should not be exposed to Androderm®. Taking testosterone may lead to a condition in which there are no sperm in the semen, and if you have risk factors, may cause sleep apnea (abnormal pauses in breathing). Your healthcare provider should monitor you for prostate specific antigen (PSA), liver function, lipids, and blood parameters. The most common adverse events in a study of 36 patients treated with Androderm® were skin irritation (itching at the application site), application site blisters, and back pain.

Androderm® is available only by prescription.

To report suspected adverse reactions, contact Watson Pharmaceuticals, Inc. at 1-800-272-5525 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see full Prescribing Information.

Models are for illustrative purposes only.